T1	Participants 64 84	malignant dysphagia.
T2	Participants 386 438	Patients with inoperable carcinoma of the oesophagus
T3	Participants 663 770	Fourteen patients were randomised to receive laser only, and 12 to receive laser followed by brachytherapy.
